What is the diagnosis and treatment for subacute viral thyroiditis?

Diagnosis and Treatment of Subacute Viral Thyroiditis

Clinical Diagnosis

Subacute thyroiditis is diagnosed clinically by the triad of anterior neck pain/tenderness, suppressed TSH with elevated thyroid hormones, and low radioactive iodine uptake, typically following a viral upper respiratory infection. 1, 2

Key Diagnostic Features:

• Neck pain and thyroid tenderness are the hallmark symptoms, often with radiation to the jaw or ears 3, 2
• Laboratory findings include suppressed TSH, elevated free T4, and markedly elevated inflammatory markers (ESR, CRP) 1, 4
• T3 measurement can be helpful in highly symptomatic patients with minimal FT4 elevations 1
• Thyroid ultrasound shows hypoechoic areas consistent with inflammation 4
• The condition typically follows an upper respiratory viral illness by 2-6 weeks 3, 2

Important Diagnostic Pitfall:

SAT can rarely present as fever of unknown origin without classic thyroid symptoms, making it easy to miss if thyroid function tests are not included in the initial workup 4

---

Treatment Algorithm Based on Symptom Severity

Mild to Moderate Disease:

For patients with mild symptoms, NSAIDs (ibuprofen 1800 mg daily or aspirin) should be the initial treatment. 1, 3, 2

• However, NSAIDs have a high failure rate (59.5% inadequate response) and often require escalation to steroids within 9-10 days 5
• NSAIDs are associated with significantly higher rates of permanent hypothyroidism (22.8% vs 6.6% with steroids) 5

Moderate to Severe Disease:

Corticosteroids (methylprednisolone 48 mg or prednisone 40 mg daily) should be used for moderate to severe symptoms, as they provide rapid symptom relief within 24-48 hours. 1, 5, 3

• Steroid therapy achieves symptomatic remission within two weeks in 100% of patients 5
• Gradually taper the dose over several weeks (typically 4-6 weeks total duration) 3
• Steroids are protective against permanent hypothyroidism (6.6% vs 22.8% with NSAIDs alone) 5
• Recurrence rates are higher with steroids (23% vs 10.5% with NSAIDs), but recurrences respond well to dose restoration 5, 3

When to Start with Steroids Directly:

Consider initiating steroid therapy immediately in patients who are anti-TPO antibody positive or have markedly elevated inflammatory markers, as these patients are at highest risk for permanent hypothyroidism. 5

---

Management of Thyroid Dysfunction Phases

Thyrotoxic Phase (Initial Weeks):

• Beta-blockers (atenolol or propranolol) for symptomatic relief of palpitations, tremors, anxiety, and fever 1, 2
• Do NOT use antithyroid drugs (methimazole, PTU) as the hyperthyroidism is due to hormone release, not overproduction 2
• Hydration and supportive care 1
• If thyrotoxicosis persists beyond 6 weeks, refer to endocrinology for additional workup to exclude other diagnoses 1

Hypothyroid Phase (Weeks to Months Later):

• Monitor thyroid function every 2-3 weeks to detect the transition to hypothyroidism 1
• Treat with levothyroxine when TSH is elevated and FT4 is low 1, 2
• For patients <70 years without cardiac disease: start full replacement at approximately 1.6 mcg/kg ideal body weight 1
• For patients >70 years or with comorbidities: start with 25-50 mcg daily 1
• In asymptomatic patients with elevated TSH but normal FT4 during recovery, consider monitoring for 3-4 weeks before treating to allow for spontaneous recovery 1

Recovery Phase Monitoring:

• If TSH becomes suppressed on levothyroxine therapy, this suggests overtreatment or thyroid recovery—reduce or discontinue the dose with close follow-up 1
• The disease is self-limited, with most patients recovering normal thyroid function within several months 3, 2
• Less than 1% develop permanent hypothyroidism when appropriately treated, though this risk is higher with NSAID-only treatment 5, 3

---

Key Clinical Considerations

Risk Factors for Permanent Hypothyroidism:

• Positive anti-TPO antibodies (strongest predictor) 5
• Treatment with NSAIDs only (versus steroids) 5
• High-level acute phase reactants 5

Follow-up Schedule:

• Monitor thyroid function every 2-3 weeks during the initial 2-3 months 1
• Continue monitoring every 4-6 weeks during the recovery phase
• Recurrences occur in approximately 20% of patients and respond to dose restoration 5, 3
• Repeat exacerbations beyond one recurrence are uncommon 3

When Conservative Management Fails:

• Thyroidectomy should be considered only in the very small minority of patients with repeated relapses despite appropriate medical treatment 3